Xenon Pharmaceuticals Inc

XENENASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
51.73 USD
↘ 1.26 (2.38%)AT CLOSE (11:59 AM EDT)
50.91
↘ 0.82 (1.59%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
50.91
↘ 0.82 (1.59%)
🔴Market: CLOSED
Open?$53.14
High?$53.61
Low?$51.52
Prev. Close?$52.99
Volume?1.7M
Avg. Volume?1.2M
VWAP?$52.50
Rel. Volume?1.39x
Bid / Ask
Bid?$44.40 × 100
Ask?$59.51 × 100
Spread?$15.11
Midpoint?$51.96
Valuation & Ratios
Market Cap?5.0B
Shares Out?96.7M
Float?68.7M
Float %?88.9%
P/E Ratio?N/A
P/B Ratio?3.74
EPS?-$3.96
Dividend?0.00%
Ex-Dividend?N/A

Xenon Pharmaceuticals Inc (XENE) is currently trading at $51.73. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
370
Market Cap
5.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xenon-pharma.com
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
74
Piotroski F-Score?0/9Weak
Altman Z-Score?59.82Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.58%Elevated
Short Interest?3.8M
Days to Cover?4.0
Free Float68.7M
Avg Daily Volume947.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?27.79Strong
Quick Ratio?27.79Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
47
3.74FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-28.6%WEAK▾
ROA?
S&P
3
-27.6%WEAK▾
Cash Flow & Enterprise
FCF?$-307252000
Enterprise Value?$4.5B
Fundamentals ratios updated end of day
MarketsMoversWatchlist